In Situ Hybridization Market Size, Demand & Share

Request Methodology

Market Snapshot (2022 to 2032)

Newly-released In Situ Hybridization industry analysis report by Future Market Insights reveals that global sales of In Situ Hybridization in 2021 were held at US$ 1.3 billion. With a 10.6% CAGR, the market is projected to reach a valuation of US$ 3.9 billion by 2032. Fluorescent In Situ Hybridization (FISH) is expected to be the highest revenue-generating technology, accounting for an absolute dollar opportunity of nearly US$ 2.5 billion from 2022 to 2032.

Attribute	Details
Global In Situ Hybridization Market (2022)	US$ 1.4 billion
Global In Situ Hybridization Market (2032)	US$ 3.9 billion
Global In Situ Hybridization Market CAGR (2022 to 2032)	10.6%
The USA In Situ Hybridization Market CAGR (2022 to 2032)	10.8%
Key Companies Profiled	Merck KGaA Thermo Fisher Scientific Agilent Technologies PerkinElmer Leica Biosystems Nussloch GmbH BIO VIEW NeoGenomics Laboratories, Inc. Bio-Rad Laboratories, Inc. Oxford Gene Technology Advanced Cell Diagnostics, Inc.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of In Situ Hybridization from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the In Situ Hybridization industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the In Situ Hybridization industry increased at around 9.9% CAGR, wherein, countries such as the USA, the Kingdom, China, South Korea, and Japan held a significant share in the global market. The market is projected to grow at a CAGR of 10.6% over the coming 10 years.

Which factors are leading to growth of the In Situ Hybridization industry?

Some of the key factors driving the market include the rising prevalence of specific disorders, increased investments in in-vitro diagnostics, and technological advances in In Situ Hybridization (ISH). Various research institutions and organizations have spent the last few years conducting extensive R&D in order to develop a technology that can evaluate the molecular profiles of single cells. For example, BIO-PROTOCOL created the Proximity Ligation in the In Situ Hybridization process. The method is expected to be high-performing, low-cost, quick multiplex, and simple to apply.

In situ hybridization technology has become more economical, making it more accessible to developing countries, which are more susceptible to infections and diseases. Regulatory organizations have implemented a variety of regulations and measures to raise public awareness. In August 2021, for example, the Federal Capital Public Health Agency in Nigeria cooperated with WHO to raise infectious illness awareness.

The utilization of ISH products has grown in recent years, resulting in an increase in the number of specialist contract research organizations. Reveal Biosciences, for example, uses in situ hybridization and other methodologies to deliver tissue research and innovative tissue technology services with strict legal capacity and high samples throughout.

For the past several years, cancer cases have been on the rise all around the world. Over the last few decades, extensive investigations on human diseases have identified recurrent genetic aberrations as potential driving factors for a range of malignancies. Cytogenetic tests, such as ISH, aid in the combination of IHC and DNA FISH in situ, allowing researchers to create, discover and execute next-generation diagnostic approaches. Direct imaging of gene expression in situ at the RNA level gives a new perspective on the interaction between cancer cells and the tumor microenvironment as cancer progresses.

Furthermore, according to a study conducted by McMaster University in Canada, the number of people living with hemophilia has tripled to 1,125,000, up from 400,000 previously. Canada, France, Italy, Australia, the United Kingdom, and New Zealand are the countries most affected. The market is anticipated to benefit from this growth.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Region is expected to offer Significant Opportunity to In Situ Hybridization Market?

North America is expected to be the most lucrative region in the In Situ Hybridization Market throughout the analysis period. The market in the region is expected to be propelled by significant expenditure in healthcare Research and Development (R&D). The market in North America is projected to cross a valuation of US$ 1.5 billion by 2032.

Country-wise Analysis

The USA In Situ Hybridization Market Analysis

The USA dominated the In Situ Hybridization market in 2021, accounting for 44.9% of the total revenue. The existence of a large number of market players, as well as encouraging research programs by the regional government, can be credited for the regional market growth.

Other variables contributing to the country's dominance throughout the projection period include high healthcare spending and strict FDA and Health Canada rules. The USA In Situ Hybridization market has the most patents, whereas the Asia Pacific market has a greater marginal rise than the rest of the world. The presence of Health Canada-funded research initiatives and institutes is estimated to spur the market by a little margin.

The United Kingdom In Situ Hybridization Market Analysis

The In Situ Hybridization market in the United Kingdom was valued at US$ 72.5 million in 2021. The market in the country is expected to reach nearly US$ 217.6 million by 2032. From 2022 to 2032, the market is likely to witness an absolute dollar opportunity of US$ 147.1 million, growing at a CAGR of 11.9%

Japan In Situ Hybridization Market Analysis

The In Situ Hybridization market in Japan is projected to reach a valuation of US$ 183.8 million by 2032, growing at a CAGR of 10.1% from 2022 to 2032. The market is likely to garner an absolute dollar opportunity of US$ 114.3 million from 2022 to 2032.

South Korea In Situ Hybridization Market Analysis

The market in South Korea is expected to reach a US$ 75.1 million market value by 2032, growing at a CAGR of 8.5% from 2022 to 2032. During this period, the market is likely to gross an absolute dollar growth of US$ 42.3 million.

Category-wise Insights

Why Fluorescent In Situ Hybridization (FISH) dominates the Market Revenue?

The Fluorescent In Situ Hybridization (FISH) segment held the largest share of In Situ Hybridization market in 2021, accounting for around 54% of total revenue. This is due to the vast range of uses, including the diagnosis of congenital illnesses such as Edward's Syndrome and Down's Syndrome. The increased use of FISH technology as a result of the rising prevalence and treatment of such diseases is likely to accelerate In Situ Hybridization market growth.

The FISH market's growth is being fueled by low-cost technical advancements. For example, in May 2021, a group of researchers published a report claiming that using chromogen-based RNA in situ hybridization to identify druggable cytokines in atopic dermatitis and psoriasis is an efficient way. Technological progress broadens the scope of In Situ Hybridization and propels segment expansion.

Why DNA segment dominated the In Situ Hybridization Market?

The DNA probe segment held the largest share of in situ hybridization market in 2021, accounting for over 50% of total revenue. However, due to the development of novel nucleic acid-based diagnostic assays and instruments for studying DNA and RNA molecules, the demand for RNA probes grew at a faster rate in the anticipated timeframe.

By hybridization, an RNA probe can indicate the presence of similar nucleic acid sequences. The use of RNA as a hybridization technique is growing due to various advantages, including the fact that the probes are generated in vitro and may be used in practically all applications instead of DNA probes.

Why Revenue through Cancer Application is expected to Dominate the Market?

Revenue through application dominated the in situ hybridization market in 2021, accounting for over 35% of the total revenue. The expansion is expected to be fueled by an increase in the number of cancer cases. According to the American Cancer Society, about 1.9 million additional cancer cases are projected in the United States in 2021. With the surge in cancer cases, in situ hybridization methods for speedy and accurate diagnosis are in high demand.

Cancer is caused by a variety of reasons, including an aging population, poor health, and the environment. Various organizations are conducting cancer research and are encouraging advancements in cancer therapy. For example, the American Institute for Cancer Research funded around USD 110 million in cancer research grants from 2020 to 2021.

How has the In Situ Hybridization Industry dealt with the Covid-19 Scenario?

During the pinnacle of the epidemic, there was a significant drop in cancer and precancer diagnoses, owing to a decline in the number of screening tests done. In recent months, these characteristics may have hampered the utility of In Situ Hybridization as a molecular tool for cancer diagnosis. However, in the forthcoming years, the considerable development of FISH probes to visualize SARS-CoV-2 RNA in infected cells can have a favorable impact on the sector.

COVID-19 was also a motivating force behind the FISH market's expansion. The University of Oxford and the University of Warwick partnered in June 2021 to develop an in situ hybridization approach for detecting the COVID-19 virus in twenty minutes. This method has previously been used to detect diseases such as the Epstein-Barr virus and HIV inside cells. The In Situ Hybridization market growth is likely to accelerate in the near future because of these changes.

Competitive Analysis

Some of the key players such as Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Leica Biosystems Nussloch GmbH.

Some of the recent developments of key In Situ Hybridization providers are as follows:

In April 2021, Applied Spectral Imaging and Kromatid entered a strategic collaboration deal to be the exclusive seller of Kromatid's Pinpoint fluorescence in situ hybridization (PPF) probes and test services.
In March 2021, Bio SB announced that the company will provide a series of CE-approved chromogenic in situ hybridization slides and fluorescent in situ hybridization slide probes for use in lung carcinomas. It was partnered with ZytoVision for the venture.
In March 2021, Roche introduced the DISCOVERY Green HRP kit, which was designed to increase the multiplexing power of immunohistochemistry (IHC) and In Situ Hybridization (ISH) by delivering different colors in contrast to existing chromogens. ONCORE Pro, Biocare Medical's completely automated staining platform for ISH and IHC applications, was released in January 2021.
In July 2019, The RNAscope HiPlex Assay was launched by Bio-Techne Corporation. The RNAscope platform is sophisticated in situ hybridization technology that allows single-molecule gene expression to be seen in intact tissues with single-cell resolution.

Similarly, recent developments related to companies offering In Situ Hybridization have been tracked by the team at Future Market Insights, which are available in the full report.

Market Segments Covered in In Situ Hybridization Industry Analysis

By Technology:

Fluorescent In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)

By Probe Type:

By Product Type:

Services
Instruments
Kits & Probes
Software

By Application:

Cancer
Cytogenetics
Developmental Biology
Infectious Diseases
Other Applications

By Region:

North America In Situ Hybridization Market
Latin America In Situ Hybridization Market
Europe In Situ Hybridization Market
Asia Pacific In Situ Hybridization In Situ Hybridization Market
Middle East and Africa In Situ Hybridization Market

Frequently Asked Questions

How much is the current worth of the In Situ Hybridization market?

The global In Situ Hybridization market is worth more than US$ 1.4 billion at present.

What is the sales forecast for In Situ Hybridization?

The value of In Situ Hybridization is projected to increase at a CAGR of around 10.6% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of In Situ Hybridization increased at a CAGR of around 9.9% from 2017 to 2021.

Who are the key players of In Situ Hybridization market?

Top five players of In Situ Hybridization market include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Leica Biosystems Nussloch GmbH

Which are the top 5 countries driving demand for In Situ Hybridization?

The top 5 countries driving demand for In Situ Hybridization are the USA, the United Kingdom., China, Japan, South Korea

Table of Content

1. Executive Summary | In Situ Hybridization Market

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage

2.2. Market Definition

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on In Situ Hybridization

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ million)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Probe Type Development Trends

4. Market Background

4.1. Market, by Key Countries

4.2. Market Opportunity Assessment (US$ million)

4.2.1. Total Available Market

4.2.2. Serviceable Addressable Market

4.2.3. Serviceable Obtainable Market

4.3. Market Scenario Forecast

4.3.1. Demand in optimistic Scenario

4.3.2. Demand in Likely Scenario

4.3.3. Demand in Conservative Scenario

4.4. Investment Feasibility Analysis

4.4.1. Investment in Established Markets

4.4.1.1. In Short Term

4.4.1.2. In Long Term

4.4.2. Investment in Emerging Markets

4.4.2.1. In Short Term

4.4.2.2. In Long Term

4.5. Forecast Factors - Relevance & Impact

4.5.1. Top Companies Historical Growth

4.5.2. Growth in Automation, By Country

4.5.3. Adoption Rate, By Country

4.6. Market Dynamics

4.6.1. Market Driving Factors and Impact Assessment

4.6.2. Prominent Market Challenges and Impact Assessment

4.6.3. Market Opportunities

4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

5.2. Banking on with Segments High Incremental Opportunity

5.3. Peer Benchmarking

6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032

6.1. Historical Market Analysis, 2017 to 2021

6.2. Current and Future Market Projections, 2022 to 2032

6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032

7.1. Historical Market Value (US$ million) Analysis, 2017 to 2021

7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ million) Analysis By Technology, 2017 to 2021

8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Technology, 2022 to 2032

8.3.1. Fluorescent (FISH)

8.3.2. Chromogenic (CISH)

8.4. Market Attractiveness Analysis By Technology

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Probe Type

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ million) Analysis By Probe Type, 2017 to 2021

9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Probe Type, 2022 to 2032

9.3.1. DNA

9.3.2. RNA

9.4. Market Attractiveness Analysis By Probe Type

10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ million) Analysis By Product Type, 2017 to 2021

10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Product Type, 2022 to 2032

10.3.1. Services

10.3.2. Instruments

10.3.3. Kits & Probes

10.3.4. Software

10.4. Market Attractiveness Analysis By Product Type

11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ million) Analysis By Application, 2017 to 2021

11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032

11.3.1. Cancer

11.3.2. Cytogenics

11.3.3. Developmental Biology

11.3.4. Infectious Diseases

11.3.5. Other Applications

11.4. Market Attractiveness Analysis By Testing Application

12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

12.1. Introduction

12.2. Historical Market Size (US$ million) Analysis By Region, 2017 to 2021

12.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. Asia Pacific

12.3.5. Middle East and Africa (MEA)

12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

13.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

13.4.1. By Country

13.4.1.1. The USA

13.4.1.2. Canada

13.4.1.3. Rest of North America

13.4.2. By Technology

13.4.3. By Probe Type

13.4.4. By Application

13.4.5. By Product Type

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Technology

13.5.3. By Probe Type

13.5.4. By Application

13.5.5. By Product Type

14. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

14.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

14.4.1. By Country

14.4.1.1. Brazil

14.4.1.2. Mexico

14.4.1.3. Rest of Latin America

14.4.2. By Technology

14.4.3. By Probe Type

14.4.4. By Application

14.4.5. By Product Type

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Technology

14.5.3. By Probe Type

14.5.4. By Application

14.5.5. By Product Type

15. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

15.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

15.4.1. By Country

15.4.1.1. Germany

15.4.1.2. France

15.4.1.3. The United Kingdom

15.4.1.4. Italy

15.4.1.5. Benelux

15.4.1.6. Nordic Countries

15.4.1.7. Rest of Europe

15.4.2. By Technology

15.4.3. By Probe Type

15.4.4. By Application

15.4.5. By Product Type

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Technology

15.5.3. By Probe Type

15.5.4. By Application

15.5.5. By Product Type

16. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

16.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

16.4.1. By Country

16.4.1.1. China

16.4.1.2. Japan

16.4.1.3. South Korea

16.4.1.4. Rest of Asia Pacific

16.4.2. By Technology

16.4.3. By Probe Type

16.4.4. By Application

16.4.5. By Product Type

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Technology

16.5.3. By Probe Type

16.5.4. By Application

16.5.5. By Product Type

17. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

17.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

17.4.1. By Country

17.4.1.1. GCC Countries

17.4.1.2. South Africa

17.4.1.3. Turkey

17.4.1.4. Rest of Middle East and Africa

17.4.2. By Technology

17.4.3. By Probe Type

17.4.4. By Application

17.4.5. By Product Type

17.5. Market Attractiveness Analysis

17.5.1. By Country

17.5.2. By Technology

17.5.3. By Probe Type

17.5.4. By Application

17.5.5. By Product Type

18. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032

18.1. Introduction

18.1.1. Market Value Proportion Analysis, By Key Countries

18.1.2. Global Vs. Country Growth Comparison

18.2. US Market Analysis

18.2.1. Value Proportion Analysis by Market Taxonomy

18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.2.2.1. By Technology

18.2.2.2. By Probe Type

18.2.2.3. By Application

18.2.2.4. By Product Type

18.3. Canada Market Analysis

18.3.1. Value Proportion Analysis by Market Taxonomy

18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.3.2.1. By Technology

18.3.2.2. By Probe Type

18.3.2.3. By Application

18.3.2.4. By Product Type

18.4. Mexico Market Analysis

18.4.1. Value Proportion Analysis by Market Taxonomy

18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.4.2.1. By Technology

18.4.2.2. By Probe Type

18.4.2.3. By Application

18.4.2.4. By Product Type

18.5. Brazil Market Analysis

18.5.1. Value Proportion Analysis by Market Taxonomy

18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.5.2.1. By Technology

18.5.2.2. By Probe Type

18.5.2.3. By Application

18.5.2.4. By Product Type

18.6. Germany Market Analysis

18.6.1. Value Proportion Analysis by Market Taxonomy

18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.6.2.1. By Technology

18.6.2.2. By Probe Type

18.6.2.3. By Application

18.6.2.4. By Product Type

18.7. France Market Analysis

18.7.1. Value Proportion Analysis by Market Taxonomy

18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.7.2.1. By Technology

18.7.2.2. By Probe Type

18.7.2.3. By Application

18.7.2.4. By Product Type

18.8. Italy Market Analysis

18.8.1. Value Proportion Analysis by Market Taxonomy

18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.8.2.1. By Technology

18.8.2.2. By Probe Type

18.8.2.3. By Application

18.8.2.4. By Product Type

18.9. BENELUX Market Analysis

18.9.1. Value Proportion Analysis by Market Taxonomy

18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.9.2.1. By Technology

18.9.2.2. By Probe Type

18.9.2.3. By Application

18.9.2.4. By Product Type

18.10. The United Kingdom Market Analysis

18.10.1. Value Proportion Analysis by Market Taxonomy

18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.10.2.1. By Technology

18.10.2.2. By Probe Type

18.10.2.3. By Application

18.10.2.4. By Product Type

18.11. Nordic Countries Market Analysis

18.11.1. Value Proportion Analysis by Market Taxonomy

18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.11.2.1. By Technology

18.11.2.2. By Probe Type

18.11.2.3. By Application

18.11.2.4. By Product Type

18.12. China Market Analysis

18.12.1. Value Proportion Analysis by Market Taxonomy

18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.12.2.1. By Technology

18.12.2.2. By Probe Type

18.12.2.3. By Application

18.12.2.4. By Product Type

18.13. Japan Market Analysis

18.13.1. Value Proportion Analysis by Market Taxonomy

18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.13.2.1. By Technology

18.13.2.2. By Probe Type

18.13.2.3. By Application

18.13.2.4. By Product Type

18.14. South Korea Market Analysis

18.14.1. Value Proportion Analysis by Market Taxonomy

18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.14.2.1. By Technology

18.14.2.2. By Probe Type

18.14.2.3. By Application

18.14.2.4. By Product Type

18.15. GCC Countries Market Analysis

18.15.1. Value Proportion Analysis by Market Taxonomy

18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.15.2.1. By Technology

18.15.2.2. By Probe Type

18.15.2.3. By Application

18.15.2.4. By Product Type

18.16. South Africa Market Analysis

18.16.1. Value Proportion Analysis by Market Taxonomy

18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.16.2.1. By Technology

18.16.2.2. By Probe Type

18.16.2.3. By Application

18.16.2.4. By Product Type

18.17. Turkey Market Analysis

18.17.1. Value Proportion Analysis by Market Taxonomy

18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017 to 2032

18.17.2.1. By Technology

18.17.2.2. By Probe Type

18.17.2.3. By Application

18.17.2.4. By Product Type

18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Concentration

19.3. Market Share Analysis of Top Players

19.4. Market Presence Analysis

19.4.1. By Regional footprint of Players

19.4.2. Probe Type footprint by Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Benchmarking

20.3. Competition Deep Dive

20.3.1. Merck KGaA

20.3.1.1. Overview

20.3.1.2. Probe Type Portfolio

20.3.1.3. Sales Footprint

20.3.1.4. Strategy Overview

20.3.2. Thermo Fisher Scientific

20.3.2.1. Overview

20.3.2.2. Probe Type Portfolio

20.3.2.3. Sales Footprint

20.3.2.4. Strategy Overview

20.3.3. Agilent Technologies

20.3.3.1. Overview

20.3.3.2. Probe Type Portfolio

20.3.3.3. Sales Footprint

20.3.3.4. Strategy Overview

20.3.4. PerkinElmer

20.3.4.1. Overview

20.3.4.2. Probe Type Portfolio

20.3.4.3. Sales Footprint

20.3.4.4. Strategy Overview

20.3.5. Leica Biosystems Nussloch GmbH

20.3.5.1. Overview

20.3.5.2. Probe Type Portfolio

20.3.5.3. Sales Footprint

20.3.5.4. Strategy Overview

20.3.6. BIO VIEW

20.3.6.1. Overview

20.3.6.2. Probe Type Portfolio

20.3.6.3. Sales Footprint

20.3.6.4. Strategy Overview

20.3.7. NeoGenomics Laboratories, Inc.

20.3.7.1. Overview

20.3.7.2. Probe Type Portfolio

20.3.7.3. Sales Footprint

20.3.7.4. Strategy Overview

20.3.8. Bio-Rad Laboratories, Inc.

20.3.8.1. Overview

20.3.8.2. Probe Type Portfolio

20.3.8.3. Sales Footprint

20.3.8.4. Strategy Overview

20.3.9. Oxford Gene Technology

20.3.9.1. Overview

20.3.9.2. Probe Type Portfolio

20.3.9.3. Sales Footprint

20.3.9.4. Strategy Overview

20.3.10. Advanced Cell Diagnostics, Inc.

20.3.10.1. Overview

20.3.10.2. Probe Type Portfolio

20.3.10.3. Sales Footprint

20.3.10.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

Table 1: Global Market Value (US$ million), By Technology, 2017 to 2021

Table 2: Global Market Value (US$ million), By Technology, 2022 to 2032

Table 3: Global Market Value (US$ million), By Probe Type, 2017 to 2021

Table 4: Global Market Value (US$ million), By Probe Type, 2022 to 2032

Table 5: Global Market Value (US$ million), By Product Type, 2017 to 2021

Table 6: Global Market Value (US$ million), By Product Type, 2022 to 2032

Table 7: Global Market Value (US$ million), By Application, 2017 to 2021

Table 8: Global Market Value (US$ million), By Application, 2022 to 2032

Table 9: Global Market, By Region, 2017 to 2021

Table 10: Global Market, By Region, 2022 to 2032

Table 11: North America Market Value (US$ million),By Technology, 2017 to 2021

Table 12: North America Market Value (US$ million),By Technology, 2022 to 2032

Table 13: North America Market Value (US$ million), By Probe Type, 2017 to 2021

Table 14: North America Market Value (US$ million), By Probe Type, 2022 to 2032

Table 15: North America Market Value (US$ million), By Product Type, 2017 to 2021

Table 16: North America Market Value (US$ million), By Product Type, 2022 to 2032

Table 17: North America Market Value (US$ million), By Application, 2017 to 2021

Table 18: North America Market Value (US$ million), By Application, 2022 to 2032

Table 19: North America Market, By Country, 2017 to 2021

Table 20: North America Market, By Country, 2022 to 2032

Table 21: Latin America Market Value (US$ million), By Technology, 2017 to 2021

Table 22: Latin America Market Value (US$ million), By Technology, 2022 to 2032

Table 23: Latin America Market Value (US$ million), By Probe Type, 2017 to 2021

Table 24: Latin America Market Value (US$ million), By Probe Type, 2022 to 2032

Table 25: Latin America Market Value (US$ million), By Product Type, 2017 to 2021

Table 26: Latin America Market Value (US$ million), By Product Type, 2022 to 2032

Table 27: Latin America Market Value (US$ million), By Application, 2017 to 2021

Table 28: Latin America Market Value (US$ million), By Application, 2022 to 2032

Table 29: Latin America Market, By Country, 2017 to 2021

Table 30: Latin America Market, By Country, 2022 to 2032

Table 31: Europe Market Value (US$ million), By Technology, 2017 to 2021

Table 32: Europe Market Value (US$ million), By Technology, 2022 to 2032

Table 33: Europe Market Value (US$ million), By Probe Type, 2017 to 2021

Table 34: Europe Market Value (US$ million), By Probe Type, 2022 to 2032

Table 35: Europe Market Value (US$ million), By Product Type, 2017 to 2021

Table 36: Europe Market Value (US$ million), By Product Type, 2022 to 2032

Table 37: Europe Market Value (US$ million), By Application, 2017 to 2021

Table 38: Europe Market Value (US$ million), By Application, 2022 to 2032

Table 39: Europe Market, By Country, 2017 to 2021

Table 40: Europe Market, By Country, 2022 to 2032

Table 41: Asia Pacific Market Value (US$ million), By Technology, 2017 to 2021

Table 42: Asia Pacific Market Value (US$ million), By Technology, 2022 to 2032

Table 43: Asia Pacific Market Value (US$ million), By Probe Type, 2017 to 2021

Table 44: Asia Pacific Market Value (US$ million), By Probe Type, 2022 to 2032

Table 45: Asia Pacific Market Value (US$ million), By Product Type, 2017 to 2021

Table 46: Asia Pacific Market Value (US$ million), By Product Type, 2022 to 2032

Table 47: Asia Pacific Market Value (US$ million), By Application, 2017 to 2021

Table 48: Asia Pacific Market Value (US$ million), By Application, 2022 to 2032

Table 49: Asia Pacific Market, By Country, 2017 to 2021

Table 50: Asia Pacific Market, By Country, 2022 to 2032

Table 51: MEA Market Value (US$ million), By Technology, 2017 to 2021

Table 52: MEA Market Value (US$ million), By Technology, 2022 to 2032

Table 53: MEA Market Value (US$ million), By Probe Type, 2017 to 2021

Table 54: MEA Market Value (US$ million), By Probe Type, 2022 to 2032

Table 55: MEA Market Value (US$ million), By Product Type, 2017 to 2021

Table 56: MEA Market Value (US$ million), By Product Type, 2022 to 2032

Table 57: MEA Market Value (US$ million), By Application, 2017 to 2021

Table 58: MEA Market Value (US$ million), By Application, 2022 to 2032

Table 59: MEA Market, By Country, 2017 to 2021

Table 60: MEA Market, By Country, 2022 to 2032

List of Charts

Figure 1: Global Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ million

Figure 3: Global Market Share, By Technology, 2022 to 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 5: Global Market Attractiveness Index, By Technology - 2022 to 2032

Figure 6: Global Market Share, By Probe Type, 2022 to 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 8: Global Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 9: Global Market Share, By Technology, 2022 to 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 11: Global Market Attractiveness Index, By Application - 2022 to 2032

Figure 12: Global Market Share, By Product Type, 2022 to 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 14: Global Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 15: Global Market Share, By Region, 2022 to 2032

Figure 16: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032

Figure 17: Global Market Attractiveness Index, By Region - 2022 to 2032

Figure 18: North America Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 19: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 20: North America Market Share, By Technology, 2022 to 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 22: North America Market Attractiveness Index, By Technology - 2022 to 2032

Figure 23: North America Market Share, By Probe Type, 2022 to 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 25: North America Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 26: North America Market Share, By Technology, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 28: North America Market Attractiveness Index, By Application - 2022 to 2032

Figure 29: North America Market Share, By Product Type, 2022 to 2032

Figure 30: North America Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 31: North America Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 32: North America Market Share, By Country, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 34: North America Market Attractiveness Index, By Country - 2022 to 2032

Figure 35: Latin America Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 36: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 37: Latin America Market Share, By Technology, 2022 to 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 39: Latin America Market Attractiveness Index, By Technology - 2022 to 2032

Figure 40: Latin America Market Share, By Probe Type, 2022 to 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 42: Latin America Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 43: Latin America Market Share, By Technology, 2022 to 2032

Figure 44: Latin America Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 45: Latin America Market Attractiveness Index, By Application - 2022 to 2032

Figure 46: Latin America Market Share, By Product Type, 2022 to 2032

Figure 47: Latin America Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 48: Latin America Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 49: Latin America Market Share, By Country, 2022 to 2032

Figure 50: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 51: Latin America Market Attractiveness Index, By Country - 2022 to 2032

Figure 52: Europe Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 53: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 54: Europe Market Share, By Technology, 2022 to 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 56: Europe Market Attractiveness Index, By Technology - 2022 to 2032

Figure 57: Europe Market Share, By Probe Type, 2022 to 2032

Figure 58: Europe Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 59: Europe Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 60: Europe Market Share, By Technology, 2022 to 2032

Figure 61: Europe Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 62: Europe Market Attractiveness Index, By Application - 2022 to 2032

Figure 63: Europe Market Share, By Product Type, 2022 to 2032

Figure 64: Europe Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 65: Europe Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 66: Europe Market Share, By Country, 2022 to 2032

Figure 67: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 68: Europe Market Attractiveness Index, By Country - 2022 to 2032

Figure 69: MEA Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 70: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 71: MEA Market Share, By Technology, 2022 to 2032

Figure 72: MEA Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 73: MEA Market Attractiveness Index, By Technology - 2022 to 2032

Figure 74: MEA Market Share, By Probe Type, 2022 to 2032

Figure 75: MEA Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 76: MEA Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 77: MEA Market Share, By Technology, 2022 to 2032

Figure 78: MEA Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 79: MEA Market Attractiveness Index, By Application - 2022 to 2032

Figure 80: MEA Market Share, By Product Type, 2022 to 2032

Figure 81: MEA Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 82: MEA Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 83: MEA Market Share, By Country, 2022 to 2032

Figure 84: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 85: MEA Market Attractiveness Index, By Country - 2022 to 2032

Figure 86: Asia Pacific Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 88: Asia Pacific Market Share, By Technology, 2022 to 2032

Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 90: Asia Pacific Market Attractiveness Index, By Technology - 2022 to 2032

Figure 91: Asia Pacific Market Share, By Probe Type, 2022 to 2032

Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 93: Asia Pacific Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 94: Asia Pacific Market Share, By Technology, 2022 to 2032

Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 96: Asia Pacific Market Attractiveness Index, By Application - 2022 to 2032

Figure 97: Asia Pacific Market Share, By Product Type, 2022 to 2032

Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 99: Asia Pacific Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 100: Asia Pacific Market Share, By Country, 2022 to 2032

Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 102: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032

November 2022

REP-GB-15793

250 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

In Situ Hybridization Market

In Situ Hybridization Market By Technology, Probe Type, Product Type, Application & Region | Forecast 2022 to 2032